Ironically, many of the staff who have already been laid off from the FDA were experts in AI modelling and machine learning, Cadotte said. "With the February 14th layoffs, 75% of those [AI experts ...

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for chronic lung disease bronchiectasis in the US. The regulator has set a ...